Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants

Clinical trial NCT03631420 · RECRUITING

Trial details

NCT number: NCT03631420
Sponsor: Meridigen Biotech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bronchopulmonary Dysplasia

Start date: 2018-10-26
Primary completion: 2025-12-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.